CENTOGENE, Denali Partnering to Recruit LRRK2 Parkinson’s Patients for Clinical Trials
News
CENTOGENE and Denali Therapeutics are teaming up to identify and recruit Parkinson’s disease patients who carry mutations in the LRRK2 gene for future clinical trials, the companies announced. CENTOGENE will ... Read more